- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
F-star Therapeutics (NASDAQ:FSTX), Quotes and News Summary
F-star Therapeutics (NASDAQ: FSTX)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-11 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.670 | -0.570 | 0.1000 | ||||
| REV | 1.300M | 2.551M | 1.251M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
F-star Therapeutics Questions & Answers
You can purchase shares of F-star Therapeutics (NASDAQ: FSTX) through any online brokerage.
Other companies in F-star Therapeutics’s space includes: Orchard Therapeutics (NASDAQ:ORTX), 89bio (NASDAQ:ETNB), Aligos Therapeutics (NASDAQ:ALGS), Infinity Pharmaceuticals (NASDAQ:INFI) and Bolt Biotherapeutics (NASDAQ:BOLT).
The latest price target for F-star Therapeutics (NASDAQ: FSTX) was reported by SVB Leerink on Wednesday, May 11, 2022. The analyst firm set a price target for 21.00 expecting FSTX to rise to within 12 months (a possible 732.94% upside). 5 analyst firms have reported ratings in the last year.
The stock price for F-star Therapeutics (NASDAQ: FSTX) is $2.5212 last updated Today at May 24, 2022, 7:19 PM UTC.
There are no upcoming dividends for F-star Therapeutics.
F-star Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for F-star Therapeutics.
F-star Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.